Women with obesity who completed supervised physical activity programs — whether face-to-face or digital — showed marked improvements in self-esteem and body image, with most gains emerging in the ...

Enfortumab vedotin-induced cutaneous toxic effects are linked to improved survival in patients with advanced bladder cancer, a cohort study shows.

From per diem shifts to solo practice, physicians share the benefits and costs of working less and living more.

Doctors who study ‘medical humanities’ have gained a deeper grasp of how classic works influence and intertwine with modern practice. And they’re better doctors for it.

Patients with high-risk locally advanced rectal cancer were randomly assigned to receive doublet-LC TNT or conventional neoadjuvant chemoradiotherapy.

Patients requiring intensive care for COVID pneumonia have reduced exercise capacity and more frequent restrictive pulmonary function patterns in the early post-COVID period.

Circulating endotrophin rises with fat gain and falls with fat loss, showing promise as a biomarker of body fat changes and a potential target for reducing obesity-linked health risks.

Once-daily oral orforglipron offers an effective weight-loss option for adults aged 65 years or older with overweight or obesity, regardless of type 2 diabetes status.

Recently approved nonhormonal options can help manage a range of symptoms, and potential new treatments are gaining momentum.

Etrasimod can be an effective and safe first-line advanced therapy option in patients with ulcerative colitis who escalate after conventional treatment failure.

Among advanced therapies for Crohn's disease, adalimumab is linked to a higher chance of maintaining clinical remission.

Higher body fat percentage, rather than BMI, is associated with reduced sperm count and disrupted reproductive hormone levels in men.